Loading…
CIK 0001776382 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("venbio-partners-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALUMIS INC | COM | $45.1M | 20.8%Prev: 10.4% | 4,619,803 SH | Increased |
| ALX ONCOLOGY HLDGS INC | COM | $11.0M | 5.1%Prev: 10.1% | 9,699,925 SH | Decreased |
| ARTIVA BIOTHERAPEUTICS INC | COM | $2.8M | 1.3%Prev: 1.9% | 648,507 SH | Decreased-500,468 SH |
| HARMONY BIOSCIENCES HLDGS IN | COM | $18.3M | 8.5%Prev: 7.6% | 489,194 SH | Increased |
| LYELL IMMUNOPHARMA INC | COM NEW | $10.4M | 4.8%Prev: 4.4% | 337,697 SH | Increased-135,782 SH |
| PHARVARIS N V | COM | $128.7M | 59.5%Prev: 65.6% | 4,639,304 SH | Increased |
| 13F-HR |
| 0000905148-26-003741 |
| $519.4M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000905148-25-002929 | $114.8M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000905148-26-002409 | $280.6M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000905148-25-001748 | $123.6M | View |